SCHEMBL329975

SCHEMBL329975

C=C(CCCO[Si](C)(C)C)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 2/20 0.36
TET2 Q6N021 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1217777 0.94 TBXAS1 (0.38) TBXAS1TET2
SCHEMBL5006417 0.92 TBXAS1 (0.41) TBXAS1
SCHEMBL840947 0.88 TET2 (0.33) TBXAS1TET2
SCHEMBL14127392 0.86
SCHEMBL27553829 0.81 ALDH1A1 (0.35)
SCHEMBL8762222 0.81
SCHEMBL5000627 0.81 TBXAS1 (0.34) TBXAS1
SCHEMBL8465648 0.79 TBXAS1 (0.36) TBXAS1
SCHEMBL156151 0.77 ALDH1A1 (0.50) TBXAS1TET2
SCHEMBL6653907 0.76 MAPT (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829606-B2 Surface modified polymer compositions LUBRIZOL ADVANCED MATERIALS, INC. 2020-11-10 US claimed
EP-3110405-B1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE INC (US) 2020-05-06 EP claimed
EP-3418319-B1 SILOXANE MONOMER, COMPOSITION FOR PREPARATION OF SILICONE HYDROGEL LENS CONTAINING SAME, AND SILICONE HYDROGEL LENS INTEROJO INC (KR) 2020-04-15 EP claimed
EP-2526150-B1 NANOCOMPOSITE HYDROGEL AND METHOD FOR PREPARING IT, FOR INDUSTRIAL AND MEDICAL APPLICATIONS FPINNOVATIONS (CA) 2018-04-25 EP claimed
EP-2500015-A1 Delivery of drugs Landec Corporation (US) 2012-09-19 EP claimed
US-7659321-B2 Photoinitiator anchored to silicate and use thereof to prepare polymer exfoliated silicate nanocomposite CORNELL RESEARCH FOUNDATION, INC. (US) 2010-02-09 US claimed
EP-2101745-A1 DELIVERY OF DRUGS LANDEC CORPORATION (US) 2009-09-23 EP claimed
US-20090012199-A1 Photoinitiator anchored to silicate and use thereof to prepare polymer exfolidated silicate nanocomposite NATIONAL SCIENCE FOUNDATION 2009-01-08 US claimed
US-20080269105-A1 Delivery of drugs ALCON RESEARCH, LLC 2008-10-30 US claimed
WO-2008070118-A9 DRUG DELIVERY LANDEC CORP (US) 2008-09-18 WO claimed
EP-0851011-B1 Ink jet inks containing emulsion polymer additives stabilized with structured polymers DU PONT (US) 2002-05-22 EP claimed
EP-1191072-A2 Electropolymerization modified carbon black and articles including tires having at least one component containing such modified carbon black THE GOODYEAR TIRE & RUBBER COMPANY (US) 2002-03-27 EP claimed
EP-1025171-A1 METHOD FOR COATING ELECTRICALLY CONDUCTIVE PARTICLES BY GRAFTING A POLYMER LAYER AND PRODUCTS RESULTING FROM SAID METHOD Cipari S.A. (LU) 2000-08-09 EP claimed
EP-0518225-B2 Aqueous pigmented inks for ink jet printers DU PONT (US) 1999-10-20 EP claimed
WO-1999020697-A1 METHOD FOR COATING ELECTRICALLY CONDUCTIVE PARTICLES BY GRAFTING A POLYMER LAYER AND PRODUCTS RESULTING FROM SAID METHOD CIPARI S.A. (LU) 1999-04-29 WO claimed
EP-0633914-B1 An aqueous ink composition DU PONT (US) 1998-10-21 EP claimed
EP-0626977-B1 ABC TRIBLOCK METHACRYLATE POLYMERS DU PONT (US) 1997-07-09 EP claimed
EP-0565709-B1 AQUEOUS INK JET INKS CONTAINING POLYOL/ALKYLENE OXIDE CONDENSATES AS COSOLVENTS DU PONT (US) 1996-11-13 EP claimed
EP-0509109-B1 Aqueous pigmented inks for ink jet printers DU PONT (US) 1995-07-12 EP claimed
EP-0096596-B2 Microelectronic device manufacture NEC CORP (JP) 1994-03-23 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012199-A1 Photoinitiator anchored to silicate and use thereof to prepare polymer exfolidated silicate nanocomposite MSN, NAPA, SELE TBXAS1 1515/4885TET2 3854/4885
US-20080269105-A1 Delivery of drugs ABCB11, ABCB1, LPXN TBXAS1 2556/4885TET2 4863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.